Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome - PubMed (original) (raw)
Review
. 2019 Apr;20(4):599-611.
doi: 10.1111/obr.12820. Epub 2018 Dec 27.
Affiliations
- PMID: 30589487
- DOI: 10.1111/obr.12820
Review
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Soo Lim et al. Obes Rev. 2019 Apr.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a chronic condition characterized by fat accumulation combined with low-grade inflammation in the liver. A large body of clinical and experimental data shows that increased flux of free fatty acids from increased visceral adipose tissue and de novo lipogenesis can lead to NAFLD and insulin resistance. Thus, individuals with obesity, insulin resistance, and dyslipidaemia are at the greatest risk of developing NAFLD. Conversely, NAFLD is a phenotype of cardiometabolic syndrome. Notably, researchers have discovered a close association between NAFLD and impaired glucose metabolism and focused on the role of NAFLD in the development of type 2 diabetes. Moreover, recent studies provide substantial evidence for an association between NAFLD and atherosclerosis and cardiometabolic disorders. Even if NAFLD can progress into severe liver disorders including nonalcoholic steatohepatitis (NASH) and cirrhosis, the majority of subjects with NAFLD die from cardiovascular disease eventually. In this review, we propose a potential pathological link between NAFLD/NASH and cardiometabolic syndrome. The potential factors that can play a pivotal role in this link, such as inflammation, insulin resistance, alteration in lipid metabolism, oxidative stress, genetic predisposition, and gut microbiota are discussed.
Keywords: cardiometabolic syndrome; inflammation; nonalcoholic fatty liver disease; oxidative stress.
© 2018 World Obesity Federation.
Similar articles
- Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
Lim S, Oh TJ, Koh KK. Lim S, et al. Int J Cardiol. 2015 Dec 15;201:408-14. doi: 10.1016/j.ijcard.2015.08.107. Epub 2015 Aug 10. Int J Cardiol. 2015. PMID: 26310987 Review. - The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease.
Ziolkowska S, Binienda A, Jabłkowski M, Szemraj J, Czarny P. Ziolkowska S, et al. Int J Mol Sci. 2021 Oct 15;22(20):11128. doi: 10.3390/ijms222011128. Int J Mol Sci. 2021. PMID: 34681787 Free PMC article. Review. - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
Santos RD, Valenti L, Romeo S. Santos RD, et al. Atherosclerosis. 2019 Mar;282:110-120. doi: 10.1016/j.atherosclerosis.2019.01.029. Epub 2019 Jan 30. Atherosclerosis. 2019. PMID: 30731283 Review. - Insulin resistance in nonalcoholic fatty liver disease.
Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Bugianesi E, et al. Curr Pharm Des. 2010 Jun;16(17):1941-51. doi: 10.2174/138161210791208875. Curr Pharm Des. 2010. PMID: 20370677 Review. - Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M, Jornayvaz FR. Asrih M, et al. Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. doi: 10.1016/j.mce.2015.02.018. Epub 2015 Feb 24. Mol Cell Endocrinol. 2015. PMID: 25724480 Review.
Cited by
- Perioperative Care for Bariatric Surgery.
Rudiman R, Hanafi RV. Rudiman R, et al. Diagnostics (Basel). 2024 Sep 23;14(18):2095. doi: 10.3390/diagnostics14182095. Diagnostics (Basel). 2024. PMID: 39335774 Free PMC article. Review. - Impact of diet intervention on visceral adipose tissue and hepatic fat in patients with obesity or type 2 diabetes: a randomized trial.
Krittayaphong R, Treesuwan W, Pramyothin P, Songsangjinda T, Kaolawanich Y, Srivanichakorn W, Jangtawee P, Yindeengam A, Tanapibunpon P, Vanavichit A. Krittayaphong R, et al. Sci Rep. 2024 Sep 13;14(1):21388. doi: 10.1038/s41598-024-72246-w. Sci Rep. 2024. PMID: 39271914 Free PMC article. Clinical Trial. - Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.
Sandireddy R, Sakthivel S, Gupta P, Behari J, Tripathi M, Singh BK. Sandireddy R, et al. Front Cell Dev Biol. 2024 Jul 16;12:1433857. doi: 10.3389/fcell.2024.1433857. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39086662 Free PMC article. Review. - Nutrition and Mental Well-Being: Exploring Connections and Holistic Approaches.
Gheonea TC, Oancea CN, Mititelu M, Lupu EC, Ioniță-Mîndrican CB, Rogoveanu I. Gheonea TC, et al. J Clin Med. 2023 Nov 20;12(22):7180. doi: 10.3390/jcm12227180. J Clin Med. 2023. PMID: 38002792 Free PMC article. - Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies.
Komic L, Kumric M, Urlic H, Rizikalo A, Grahovac M, Kelam J, Tomicic M, Rusic D, Ticinovic Kurir T, Bozic J. Komic L, et al. Life (Basel). 2023 Jun 10;13(6):1365. doi: 10.3390/life13061365. Life (Basel). 2023. PMID: 37374147 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical